Content about Otsuka Pharmaceutical

March 1, 2013
FDA approves Abilify Maintena for schizophrenia

The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.

January 15, 2013
Reports: Otsuka can block Apotex's generic version of Abilify

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

February 17, 2011
FDA OKs Abilify as maintenance treatment for bipolar disorder

The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

October 7, 2010
Supplements with natural S-equol may reduce joint pain, hot flashes in postmenopausal women

A new women's health, whole soy germ-based nutritional supplement containing natural S-equol reduced the frequency...

© 2013 Drug Store News. All Rights Reserved.